Selected article for: "blood lymphopenia and disease severity"
Author: Hengeveld, Paul J.; Khader, Aaram O.; de Bruin, Linda H. A.; Geelen, Inge G. P.; van Baalen, Eske A.; Jansen, Eva; Bouwer, Nathalie I.; Balak, Ömer; Riedl, Jurgen A.; Langerak, Anton W.; Westerweel, Peter E.; Levin, Mark‐David
Title: Blood cell counts and lymphocyte subsets of patients admitted during the COVID‐19 pandemic: a prospective cohort study
  • Cord-id: xrwsv0r8
  • Document date: 2020_7_28
    • ID: xrwsv0r8
    Snippet: Aberrant blood cell counts, most prominently lymphopenia, have been identified as markers of the degree of severity of coronavirus disease 2019 (COVID-19) (Terpos et al, 2020; Yang et al, 2020; Wan et al, 2020; Wang et al, 2020; Zhao et al, 2020). However, most of these studies lack comparison to a COVID-19 negative, contemporary control group. Additionally, the longitudinal composition and dynamics of lymphocyte subsets in COVID-19 patients are insufficiently characterized.
    Document: Aberrant blood cell counts, most prominently lymphopenia, have been identified as markers of the degree of severity of coronavirus disease 2019 (COVID-19) (Terpos et al, 2020; Yang et al, 2020; Wan et al, 2020; Wang et al, 2020; Zhao et al, 2020). However, most of these studies lack comparison to a COVID-19 negative, contemporary control group. Additionally, the longitudinal composition and dynamics of lymphocyte subsets in COVID-19 patients are insufficiently characterized.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lymphocyte subset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory syndrome and lymphocyte subset count: 1
    • acute respiratory syndrome and lymphopenia prevalence: 1, 2
    • longitudinal analysis and low prevalence: 1, 2
    • longitudinal analysis and lymphocyte count: 1
    • low prevalence and lymphopenia prevalence: 1, 2